'He Is Not a Comic Book Super-Villain': What We Heard This Week
Quotable quotes heard by <em>MedPage Today</em>'s reporters
Stay updated with breaking news from Practice Innovation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quotable quotes heard by <em>MedPage Today</em>'s reporters
Alisertib as monotherapy and in combination with fulvestrant stands at the forefront of the clinical investigation of selective AURKA pathway inhibition in patients with endocrine-resistant advanced breast cancer, according to Tufia C. Haddad, MD.
Less than 20% of physicians were open to starting a patient with nonvalvular atrial fibrillation on an anticoagulant after conducting a clinical review of the patient’s care.
U.S. spends most on health care but has worst health outcomes: report-
U.S. spends most on health care but has worst health outcomes: report-